The physiological changes in the thyroid gland during pregnancy were well understood. Serum 
Introduction
Hypertensive disease in pregnancy is a major cause of maternal and fetal morbidity and mortality 1 . PE adversely affects the maternal and fetal outcome due to its wide spread multi organ involvement. PE is a complication in approximately 5% of all pregnancies 1 .
The incidence in primigravida is about 10% and in multigravida 5%. PE is one of the most common causes of perinatal morbidity and mortality resulting in an estimated 35 ~ 300 deaths per 1000 births depending on neonatal support 1 .
PE usually occurs in women at both extremes of reproductive age however the risk of PE is greatest in women younger than 20 years 1 . PE is more prevalent in developing countries like Bangladesh where poverty, malnutrition, micronutrient deficiencies, early marriage, early child birth and lack of antenatal care are more common.
In Bangladesh the incidence of PE is very high. It is about 10 ~ 15% of all deliveries and it remains one of the commonest (about 16%) cause of maternal death being in the third position of all MMR 2 .
So preeclampsia is a matter of great concern for the obstetrician as well as pregnant women and for the nation. The exact cause of preeclampsia has not been identified. Numerous theories of potential causes exist including genetic, dietary, vascular and auto immune factors 3 . The causes of PE remains unknown however placental dysfunction many initiate the systematic vasospasm, ischemia and thrombosis that eventually damages maternal organs.
The mechanism of hypothyroidism in preeclamptic women has not been identified but the changes in thyroid function during pregnancy are accounted for high circulating oestrogen 4 . There are different views about the mechanism and clinical significance of low concentrations of thyroid hormones in PE, which are attributed to decrease plasma protein concentrations and high levels of endothelin, a potent vasoconstrictor produced by vascular endothelium after a vascular injury 5, 6 . There is a relationship between PE and thyroid profile. Serum TSH level significantly increased without concomitant changes in T 3 and T 4 in PE compared to normal pregnancy 7 . Thus TSH was found to be strong associating factor for the occurrence of PE.
Materials and Methods
This was a descriptive cross sectional study. consecutively admitted with the diagnosis of preeclampsia in the third trimester were recruited for the study.
The inclusion criteria were: (a) Preeclamptic patients in the third trimester of pregnancy, (b) Healthy pregnant women in the third trimester of pregnancy.
The exclusion criteria for both the groups were: (a) The patient with pregnancy induced hypertension (PIH) without proteinuria, (b) the pregnant women with previous history of thyroid diseases or metabolic disorders, maternal history of taking antithyroid drugs, (c) History of thyroid surgery or treatment with RAI, (d) Pregnancy with chronic renal disease, (e) History of multiple pregnancies, (f) Pregnancy with chronic hypertension, (g) Chronic liver disease and (h) Medication with diuretics, steroids and anti-HTN drugs. 10 ml venous blood sample was taken from the cubital vein of (i) preeclamptic women, after the diagnosis was made but before the initiation of the antihypertensive treatment, and before the delivery and (ii) each control subject as mentioned above. All samples were sent to the laboratory with different code numbers. Sera was separated and stored at -20 o C until assayed. Free T 3 (triiodothyronine), free T 4 (thyroxine) and TSH (thyroid-stimulating hormone) were measured using radioimmunoassay. All women were followed up through their antenatal, intrapartum and postpartum period. They were especially observed for the development of the symptoms and signs of hypothyroidism. Data were statistically analyzed by computer with SPSS (Version 11.5). Mean values were calculated to see the central tendency, standard deviation, standard error were calculated to assess the dispersion of the data and the Student's 't' test, Chi-square test were performed to detect statistical significance of the observations. A probability value (p -value) of < 0.05 was considered significant with 95% CI.
Results
A total 104 pregnant women were included in this study. Among them 52 women with the diagnosis of preeclampsia selected as Case and 52 were normal pregnant women as control.
Age, parity and gestational age of participant group:
The mean (±SD) age of the study group and control group were 26.15±4.17 years and 26.19±4.20 years respectively and there was no statistically significant difference between the two groups (p > 0.05).
The mean (±SD) parity of the study group and control group were 1.28±0.90 years and 1.30±0.88 years respectively and there was no statistically significant difference between the two groups (p > 0.05).
The mean (±SD) gestational age at the time of taking the blood sample for thyroid hormonal level was 34.30±2.92 weeks in the study group and 35.10±2.82 weeks was in the control group. The difference between the two groups was not statistically significant (p = 0.55). The results are shown in Table- 
Thyroid function tests
The mean (±SD) TSH of the study group and control group were 4.14±2.24 mIU/L and 2.75±1.73 mIU/L respectively and there was highly significant difference between the two groups (p = 0.0007). The mean (±SD) T 3 of the study group and control group were 1.95±0.64 nmol/L and 1.98±0.57 nmol/L respectively and there was no significant difference between the two groups (p > 0.05). The mean (±SD) T 4 of 128.38±33.43 nmol/L was in the study group and 126.37±34.70 nmol/L was in the control group. The difference between the two groups was not statistically significant (p > 0.05). The results are shown in Table- II.
Table -II: Thyroid function tests of participants groups
TSH levels of both case and control groups Out of 52 pregnant women in study group, 21 (40.40%) had higher TSH titers (> 4.8 mIU/L) and 52 pregnant women in control group, 9 (17.30%) had higher TSH titers (> 4.8 mIU/L). Twenty one (70.00%) of the 30 pregnant women with abnormal TSH titers, had the diagnosis of preeclampsia whereas 31 (41.90%) of the 74 pregnant women with normal TSH titers, had preeclampsia in the third trimester. This difference between the two groups was statistically significant (p = 0.009), degrees of freedom was 1. Odds ratio indicates that preeclampsia group have chance of higher TSH (>4.8 mIU/L) by 3.24 times. The results are shown in Table- III. 5 .
In this study the mean (±SD) gestational age at the time of taking blood sample for thyroid hormonal levels was 34.30±2.92 weeks in the study group and 35.10±2.85 weeks was in the control group. The difference between the groups was not statistically significant (p = 0.55). The mean (±SD) parity of the study group and control group were 1.28±0.90 and 1.30±0.88 respectively and there was no difference between the two groups (p> 0.05).
It was also similar to the other studies, Larijani et al found the mean (±SD) gestational age was 35.67±6.88 weeks was group and the mean (±SD) parity was 2.51±1.43 in the study group and 2.98±1.75 was in the control group 10 .
In this research work, the mean (±SD) TSH of the study group and control group were 4.14 ± 2.24 mIU/L and 2.75±1.73 mIU/L respectively and there was highly significant different between the two groups (p = 0.0007).
The mean (±SD) T 3 of the study group and control group were 1.95±0.64 nmol/ L and 1.98 ± 0.57 nmol/L respectively and there was no difference between the two groups (p>0.05). The mean (±SD) T 4 of 128.38 ± 33.43 nmol/L was in the study group and 126.37 ± 34.70 nmol/L was in the control group. The difference between the two groups was not statistically significant (p>0.05).
The mean values of thyroid hormones were with in normal laboratory ranges in both the group. The mean T 3 and T 4 titres were not significantly different in the two groups (T 3 , p = 0.79 and T 4 , p=0.76). The mean TSH value was significantly higher in the problematic women than the control (p<0.0007) degree of freedom was 102).
These results were similar to the findings of Kumar et al in the antenatal clinic of a public hospital of Delhi where they found the mean (±SD) TSH of the study group and control group were 4.6 ± 3.64 mIU/L and 2.5 ± 2.01 mIU/L respectively and there was highly significant difference between the two groups (p<0.001) 7 .
Lao TT et al in their study found that normotensive women and preeclamptic patients had ignorantly higher TSH (p<0.001) while T 4 and T 3 concentration were slightly low but not significantly lower in the third trimester of pregnancy 5 .
There were similar studies, Larijani reported that the observed reduced serum concentration regarding the T 4 and T 3 reflect the severity of PE. Confirmatory to these report in their study mild cases of PE had lower level of T 3 and T 4 than healthy controls. It had been suggested that the reduced concentration of T 3 and T 4 levels might be explained by the loss of protein and protein bound hormones. Since T 3 is mostly the product of peripheral conversion of T 4 , the involvement of organs such as the liver and kidneys contributes to low level of T 3 8 .
In the present study, only TSH is significantly increased in preeclamptic patients at the time of diagnosis as compares to control subjects. The researches findings was also similar to the findings fo the reports that preeclamptic women had higher incidence of biochemical hypothyroidism compares with normotensive pregnant women 6 . Mild alternation in the thyroid hormones might occur due to non-thyroidal illness acting as a stress factor as well as due to decreased plasma albumin concentration in these patients 9 . Serum T 3 and T 4 were decreases significantly and TSH was increased significantly in preeclamptic women in their third trimester 11 . The titres of T 3 are reported to be significantly related to the decreased plasma albumin concentration in preeclamptic women 5 . It has been suggested that reduced serum concentrations of thyroid hormones in toxemia may be due to the loss of protein and protein-bound hormones in the urine. Modest decreases in thyroid hormones with concomitant increases in TSH levels in maternal serum correlated with severity of PE or eclamptic and high levels of endothelin 6 . The endothelial cell dysfunction plays an important role in the pathogenesis of PE.
In this study TSH levels of both case and control groups were: Out of 52 pregnant women in study group, 21 (40.40%) had higher TSH titers (>4.8 mIU/L) and 52 pregnant women in control group, 9 (17.30%) of the 30 pregnant women with abnormal TSH titles, had the diagnosis of PE whereas 31 (41.90%) of the 74 pregnant women with normal TSH titers, had PE in the third trimester. This difference between the two groups was found statistically significant (p = 0.009), degrees of freedom was 1. Odds Ratio indicates preeclamptic group had change of higher TSH by 3.24 times than the normal group.
The difference in the number of pregnant women of the two groups, having high TSH titres was also significant. More number of preeclamptic women had increased TSH levels at the time of diagnosis when compares with normotensive pregnant women. Kumar et al also observed statistically significant higher number of cases with PE (76.7%) in pregnant women with abnormally high levels of TSH 7 . Diseases of the thyroid gland itself are a predisposing factor for the development of PE 12 .
